Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
The primary aim of our working group is the same as the one ESC promotes; "To reduce the burden of cardiovascular disease in Europe".
Pharmacology is an extremely important aspect of most disciplines within cardiology. All cardiologists use cardiovascular drugs and we believe all cardiologist who are ESC members should join our working group to contribute and to learn. Thus, we are an important contributor to the ESC at most levels. We work with all aspects of cardiovascular pharmacology i.e. from basic pharmacology over clinical trials to clinical pharmacology. The activity of the working group has increased dramatically during the last years. We have now yearly scientific meetings organized by the working group focusing on cardiovascular pharmacology. We have several other educational activities, which we plan to increase during the next years and we have recently launched a new journal within the European Heart Journal family, entitled European Heart Journal – Cardiovascular Pharmacotherapy.
Prof. Basil S. Lewis, FESC (Israel)Chairperson 2016-2018